Methods of cost-effectiveness analysis: areas of consensus and debate
- 28 February 1995
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 17 (1) , 109-125
- https://doi.org/10.1016/0149-2918(95)80012-3
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Health-Related Quality of Life Assessment and the Pharmaceutical IndustryPharmacoEconomics, 1992
- Preference Based Outcome Measures for Economic Evaluation of Drug InterventionsPharmacoEconomics, 1992
- Meta-Analysis and Quality of Evidence in the Economic Evaluation of Drug TrialsPharmacoEconomics, 1992
- Quality of Life Instruments in the Evaluation of New DrugsPharmacoEconomics, 1992
- Standardisation of Quality of Life TrialsPharmacoEconomics, 1992
- Economic Analysis as an Aid to Subsidisation DecisionsPharmacoEconomics, 1992
- Pharmacoeconomics of Genetically Engineered DrugsPharmacoEconomics, 1992
- Principles of Pharmacoeconomic Analysis of Drug TherapyPharmacoEconomics, 1992
- Economic Evaluation of PharmaceuticalsPharmacoEconomics, 1992
- Economic evaluation and the rational diffusion and use of health technologyHealth Policy, 1987